Literature DB >> 21613340

Tridimensional personalities and polymorphism of dopamine D2 receptor among heroin addicts.

Lay K Teh1, Abu F Izuddin, Fazleen H M H, Zainul A Zakaria, Mohd Zaki Salleh.   

Abstract

BACKGROUND: Drug addiction is a multifactorial disorder. Researchers have posited that an individual's inherited behavioral propensity or temperament contributes to the disorder by shaping a personality strongly linked with the risk of drug abuse. Further, they hypothesize that the polymorphism of dopamine D2 receptor increases the susceptibility to and severity of addiction. We, therefore, investigated possible associations between dopamine D2 receptor (DRD2) and personality traits among intravenous heroin addicts.
METHODS: We assessed 93 intravenous heroin addicts and controls using Diagnostic and Statistical Manual, Fourth Edition (DSM-IV) and the Tridimensional Personality Questionnaire (TPQ). We confirmed drug-dependence status using a questionnaire based on DSM-IV criteria. We extracted DNA from the subjects' whole blood and genotyped it for DRD2 allelic variants.
RESULTS: Genotype analysis showed a significantly higher frequency for the TaqIA polymorphism among the addicts (69.9%) compared to control subjects (42.6%; Fisher's exact χ(2), p < .05). We observed no significant differences for other variants between the addicts and controls. The addicts had higher scores for novelty seeking (NS) and harm avoidance (HA) personality traits but lower scores for reward dependence (RD) when compared to control subjects. LIMITATION: The environmental cues are different for the addicts, and the healthy university students we used as controls. We recommend that researchers employ a gene-environment interaction approach to study factors associated with addictive behaviors in future studies.
CONCLUSION: Taq1A may be implicated for an increased vulnerability to addiction. Screening of this marker might be useful for identifying individuals at risk of addiction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21613340     DOI: 10.1177/1099800411405030

Source DB:  PubMed          Journal:  Biol Res Nurs        ISSN: 1099-8004            Impact factor:   2.522


  6 in total

1.  Dopamine Genetics and Function in Food and Substance Abuse.

Authors:  K Blum; M Oscar-Berman; D Barh; J Giordano; Ms Gold
Journal:  J Genet Syndr Gene Ther       Date:  2013-02-10

2.  Exaggerated acquisition and resistance to extinction of avoidance behavior in treated heroin-dependent men.

Authors:  Jony Sheynin; Ahmed A Moustafa; Kevin D Beck; Richard J Servatius; Peter A Casbolt; Paul Haber; Mahmoud Elsayed; Lee Hogarth; Catherine E Myers
Journal:  J Clin Psychiatry       Date:  2016-03       Impact factor: 4.384

3.  Influence of DRD2 Polymorphisms on the Clinical Outcomes of Opioiddependent Patients on Methadone Maintenance Therapy.

Authors:  Zalina Zahari; Chee Siong Lee; Muslih Abdulkarim Ibrahim; Nurfadhlina Musa; Mohd Azhar Mohd Yasin; Yeong Yeh Lee; Soo Choon Tan; Nasir Mohamad; Rusli Ismail
Journal:  J Pharm Bioallied Sci       Date:  2020-11-05

4.  Generational association studies of dopaminergic genes in reward deficiency syndrome (RDS) subjects: selecting appropriate phenotypes for reward dependence behaviors.

Authors:  Kenneth Blum; Amanda L C Chen; Marlene Oscar-Berman; Thomas J H Chen; Joel Lubar; Nancy White; Judith Lubar; Abdalla Bowirrat; Eric Braverman; John Schoolfield; Roger L Waite; Bernard W Downs; Margaret Madigan; David E Comings; Caroline Davis; Mallory M Kerner; Jennifer Knopf; Tomas Palomo; John J Giordano; Siobhan A Morse; Frank Fornari; Debmalya Barh; John Femino; John A Bailey
Journal:  Int J Environ Res Public Health       Date:  2011-11-29       Impact factor: 3.390

5.  Relationship among methadone dose, polymorphisms of dopamine D2 receptor and tri-dimensional personality questionnaire in heroin-addicted patients.

Authors:  Min-Wei Huang; Tai-An Chiang; Pei-Yu Lo; Ching-Shan Huang
Journal:  Behav Brain Funct       Date:  2016-08-31       Impact factor: 3.759

Review 6.  Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders.

Authors:  Jamie A Burns; Danielle S Kroll; Dana E Feldman; Christopher Kure Liu; Peter Manza; Corinde E Wiers; Nora D Volkow; Gene-Jack Wang
Journal:  Front Psychiatry       Date:  2019-09-18       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.